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A Case of Sheehan’s Syndrome that Manifested as Bilateral Ptosis 
Hypothyroidism can cause a variety of signs and symptoms of the neuromuscular system. 
However, ptosis in a patient with hypothyroidism is very rare. We report here on a case of 
central hypothyroidism that was due to Sheehan’s syndrome and it manifested as bilateral 
ptosis in a 51-yr-old woman. She complained of exertional dyspnea and weakness. About 
25-yr ago, she had a history of severe postpartum vaginal bleeding. The laboratory studies 
demonstrated hypopituitarism with secondary hypothyroidism. The ptosis was improved by 
replacement of thyroid hormone. Hypothyroidism should be considered in the differential 
diagnosis of patients who manifest with ptosis and that prompt replacement of hormone 
can lead to a complete recovery.
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CASE REPORT
Endocrinology, Nutrition & Metabolism
INTORDUCTION
 
Ptosis may be due to myogenic, neurogenic, aponeurotic, me-
chanical or traumatic causes. The most frequent disorder caus-
ing myogenic ptosis is myasthenia gravis (1). Hypothyroidism 
can cause a variety of signs and symptoms of the neuromuscu-
lar system (2). However, in the absence of other obvious etiolo-
gies, ptosis in a patient with hypothyroidism is very rare (3-5). 
We report here on a case of central hypothyroidism that was 
due to Sheehan’s syndrome and the patient manifested with bi-
lateral ptosis, and the patient was initially suspected as having 
myasthenia gravis.  
CASE DESCRIPTION
The patient was a 51-yr-old woman with swelling of the extrem-
ities and bilateral ptosis on March 8, 2010. She complained of 
exertional dyspnea and weakness. She married at the age of 25. 
After that time, she developed drooping of her eyes, with the left 
eye drooping more than the right eye. Her symptoms persisted 
and they had gradually increased during about the last 10 yr. 
About 8 yr ago, she underwent a ptosis repair operation at a lo-
cal clinic, but her symptoms were not improved. She denied a 
history of loss of consciousness, headache, dysphagia, dysarthria 
and myalgia. There was no family history of similar symptoms 
and no history of trauma. There was no previous history of dia-
betes and hypertension.
  On examination, she was determined to be 151 cm in height 
and 48 kg in weight. The initial vital signs were a blood pressure 
of 140/80 mmHg, a pulse rate of 68 beats/min and a respiratory 
rate of 20/min. She was lethargic and had facial puffiness and 
no goiter. The lung and heart examinations were unremarkable. 
All the extremities showed pitting. She had marked bilateral pto-
sis, while the external ocular movements were normal (Fig. 1A). 
The other cranial nerve examinations were unremarkable. 
  The laboratory findings were a total leucocyte count 4.75 × 
10
3/μL with 61.6% polymorphs, a hemoglobin level of 9.0 g/dL, 
the random blood glucose was 124 mg/dL, the serum sodium 
was 130 mM/L, the potassium was 3.7 mM/L, the blood urea 
nitrogen (BUN) was 13 mg/dL, the creatinine was 0.8 mg/dL, 
the aspartate transaminase (AST) was 81 IU/L, the alanine trans-
aminase (ALT) was 29 IU/L, the total bilirubin was 0.93 mg/dL, 
the creatine kinase (CK) was 1,195 IU/L (normal reference: 20-
180 IU/L ), the lactate dehydrogenase (LDH) was 517 IU/L (nor-
mal reference: 101-218 IU/L), the total cholesterol was 256 mg/
dL, the triglyceride was 121 mg/dL, the high density lipoprotein 
cholesterol (HDL-C) was 40 mg/dL and the low density lipopro-
tein cholesterol (LDL-C) was 196 mg/dL. The urinary analysis 
was negative for blood and protein with using a dipstick. As the 
clinical findings suggested hypothyroidism and myasthenia 
gravis, a thyroid function test and acetylcholine receptor bind-
ing antibody test were done. The serum T3 was 0.195 ng/mL 
(normal reference: 0.86-2.02 ng/mL), the free T4 was 0.08 ng/
dL (normal reference: 0.93-1.705 ng/dL), the thyroid-stimulat-
ing hormone (TSH) was 2.08 μIU/mL (normal reference: 0.27-
4.2 μIU/mL), the antimicrosomal antibody was 17 IU/mL (nor-
mal reference: 0-34 IU/mL), the antithyroglobulin antibody was 
20.1 IU/mL (normal reference: 0-114 IU/mL) and the acetyl-
choline receptor binding antibody was negative. 
  Secondary hypothyroidism was suspected. We performed a 
careful history taking and other pituitary hormone evaluations. 
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a history of massive postpartum vaginal bleeding. Thereafter she 
not resumed menses. The basal levels of other hormones were 
a serum cortisol of 4.03 μg/dL, the adrenocorticotropic hormone 
(ACTH) was 29.64 pg/mL, the growth hormone (GH) was 0.06 
ng/mL, the IGF-1 was 25 ng/mL (normal reference: 71-263 ng/
mL), the prolactin was 1.59 ng/mL, the luteinizing hormone 
(LH) was 1.49 IU/L, the follicle-stimulating hormone (FSH) was 
4.91 IU/L, the E2 was 17.29 pg/mL and the testosterone was 0.02 
ng/mL. The combined pituitary stimulation test, including the 
insulin tolerance test, the thyrotropin-releasing hormone (TRH) 
stimulation test and the gonadotropin-releasing hormone (GnRH) 
stimulation test showed panhypopituitarism (Table 1). Brain 
magnetic resonance imaging (MRI) showed a finding of an emp-
ty sella turcica and there was no evidence of an intracranial mass, 
hemorrhage and aneurysm (Fig. 2).
  Nerve conduction study (NCS) and electromyography (EMG) 
of the limbs reveled normal results with the exception of inci-
dentally detected carpal tunnel syndrome. Needle EMG of the 
orbicularis oculi showed no evidence of dysfunction of the neu-
romuscular junction.
  We diagnosed her as having Sheehan’s syndrome, bilateral 
ptosis and subclinical myopathy caused by secondary hypothy-
roidism. Replacement with prednisolone of 10 mg/day and thy-
roxine (T4) 100 μg/day was started. The dose of prednisolone 
was decreased to 5 mg/day after 4 weeks. At 3 months follow-up, 
she had become euthyroid with normalized muscle enzymes. 
She recovered from her presenting symptoms and the bilateral 
ptosis was much improved (Fig. 1B). 
DISCUSSION
Sheehan’s syndrome occurs as a result of ischemic pituitary ne-
crosis due to severe postpartum hemorrhage. Although a small 
percentage of patients with Sheehan’s syndrome may have an 
abrupt onset of severe hypopituitarism immediately after deliv-
ery, most patients have mild disease and they go undiagnosed 
for a long time and they are treated inappropriately (6). In this 
current patient, chronic fatigue and weakness had persisted, 
but it had gone undiagnosed for about 20 yr. 
  Initially, her symptoms such as ptosis, progressive dyspnea 
and weakness were suspicious for myasthenia gravis. Myasthe-
nia gravis is an acquired neuromuscular disorder that is char-
acterized by fatigability and fluctuating weakness of the skeletal 
muscles, and especially eye muscle weakness. The weakness is 
Table 1. Results of the combined pituitary stimulation test
Time (min) Glucose (mg/dL) GH (ng/mL) Cortisol (µg/dL) Prolactin (ng/mL) TSH (µU/mL) LH (IU/L) FSH (IU/L)
    0   82 0.06 4.03 1.59 2.08 1.49 4.91
  30   39 0.07 4.32 2.02 2.66 2.56 5.27
  60 202 0.16 4.44 1.59 2.65 3.04 4.96
  90 108 0.14 4.42 1.55 2.66 3.51 5.67
120   62 0.06 3.87 1.40 2.6 3.22 5.60
GH, growth hormon; TSH, thyoid-stimulating hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone. 
A
B
Fig. 1. Bilateral ptosis before (A) and 3 months after (B) replacement of thyroid hor-
mone.
Fig. 2. The sagittal noncontrast T1 weighted magnetic resonance image of the brain 
shows an enlarged sella turcica and a nonvisualized gland. Lee YS, et al.  •  Sheehan’s Syndrome Manifested as Bilateral Ptosis 
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caused by circulating antibodies that block the acetylcholine 
receptors at the postsynaptic neuromuscular junction, and this 
inhibits the stimulative effect of the neurotransmitter acetyl-
choline (7). In most cases, the first noticeable symptom is weak-
ness of the eye muscles. Therefore, the presence of ptosis neces-
sitates the exclusion of underlying ocular myasthenia gravis (4). 
In this patient, the acetylcholine receptor binding antibody was 
negative and needle EMG of the orbicularis oculi showed no 
evidence of dysfunction of the neuromuscular junctions. Also, 
the ptosis was improved by replacement of thyroid hormone. 
Therefore, myasthenia was adequately excluded. 
  Ptosis has been previously reported in patients with primary 
hypothyroidism, but there have been only a few case reports (3-
5). In patients with hypothyroidism, myopathy, mononeuropa-
thy and diffuse peripheral polyneuropathy may encountered 
with various incidences (8). Carpal tunnel syndrome is the most 
frequently observed in hypothyroidism. Polyneuropathy and 
myopathy are also well known (8). Patients can complain of mus-
cle and joint pain, cramps, fatigue and weakness. However, in-
volvement of a cranial nerve in a patient with hypothyroidism is 
very rare. Although neuromuscular complications are well rec-
ognized in thyroid disorders, their pathophysiology remains un-
clear. Generally, these abnormalities are secondary to mucopoly-
saccharide infiltration of various peripheral organs (5). Cho et 
al. (9) described a case of pituitary apoplexy with Sheehan’s syn-
drome and isolated third cranial nerve palsy. In their case, direct 
mechanical compression of the third cranial nerve or the vas-
cular supply to the nerve resulted in a sudden onset of isolated 
third cranial nerve palsy. The patient’s ptosis was improved by 
surgical decompression. However, our patient had long stand-
ing secondary hypothyroidism and the ptosis had an insidious 
onset. The patient’s ptosis was improved by replacement of hor-
mone. 
  Moderate myopathy frequently develops in patients with hy-
pothyroidism. This myopathy is most often manifested as myal-
gia, muscle stiffness, cramps and sometimes elevated plasma 
levels of creatinine phosphokinase. Infrequently, rhabdomyoly-
sis can also develop in patients with hypothyroidism (10). Our 
patient had no specific symptoms of myopathy, but she had el-
evated levels of muscle enzyme. After replacement of hormone, 
the muscle enzymes were normalized. 
  Adrenal insufficiency is can produce generalized muscle 
weakness, muscle cramping and fatigue. However, except for 
generalized weakness, musculoskeletal manifestations have 
rarely been described in adrenal insufficiency (11) and which is 
thought to be due to the electrolyte abnormalities in primary 
adrenal insufficiency (12). Our patients had secondary adrenal 
insufficiency and mild hyponatremia. Therefore we thought 
that our patient’s musculoskeletal manifestations with ptosis is 
due to mainly central hypothyroidism.
  We report here on an unusual case of ptosis associated with 
central hypothyroidism due to Sheehan’s syndrome. It is con-
cluded that hypothyroidism should be considered in the differ-
ential diagnosis of patients who manifest with ptosis and that 
prompt replacement of hormone can lead to a complete recov-
ery. 
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